Iridium to Participate in 2016 Wells Fargo Technology, Media & Telecom Conference
Nov 02, 2016 12:00 pm UTC| Business
MCLEAN, Va., Nov. 02, 2016 -- Iridium Communications Inc. (Nasdaq:IRDM) today announced that Chief Executive Officer Matthew J. Desch is scheduled to speak at the 2016 Wells Fargo Technology, Media Telecom Conference...
NORDSEE Selects Mitel for Seamless Cloud Communications and Collaboration
Nov 02, 2016 12:00 pm UTC| Business
Cloud and collaboration tools to offer simpler, more flexible ways of workingMobile-first capabilities designed to drive efficiencies between headquarters and field workersHarmonized communications infrastructure across...
VBL Therapeutics to Report Third Quarter 2016 Financial Results on November 10
Nov 02, 2016 12:00 pm UTC| Business
TEL AVIV, Israel, Nov. 02, 2016 -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today...
Industry Veteran Sal Ventura Joins Hazeltree to Lead Client Relationship Management
Nov 02, 2016 12:00 pm UTC| Business
NEW YORK, LONDON AND HONG KONG, Nov. 02, 2016 -- Hazeltree, the leading provider of integrated buy-side treasury management solutions, today expanded its management team by hiring industry veteran Sal Ventura as head of...
Spectranetics Files PMA Application for FDA Approval of the Stellarex™ Drug-Coated Balloon
Nov 02, 2016 12:00 pm UTC| Business
COLORADO SPRINGS, Colo., Nov. 02, 2016 -- The Spectranetics Corporation (NASDAQ:SPNC) announced today that it has submitted to the Food Drug Administration (FDA) its Pre-Market Approval (PMA) application for the...
Nov 02, 2016 12:00 pm UTC| Business
HOUSTON, Nov. 02, 2016 -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid...
Intra-Cellular Therapies to Host Third Quarter 2016 Financial Results Conference Call and Webcast
Nov 02, 2016 12:00 pm UTC| Business
NEW YORK, Nov. 02, 2016 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that it will...